(NASDAQ: LONA) Leonabio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.33%.
Leonabio's earnings in 2026 is -$37,723,000.On average, 4 Wall Street analysts forecast LONA's earnings for 2026 to be -$16,392,766, with the lowest LONA earnings forecast at -$20,020,748, and the highest LONA earnings forecast at -$12,299,012.
In 2027, LONA is forecast to generate -$8,367,351 in earnings, with the lowest earnings forecast at -$8,039,219 and the highest earnings forecast at -$8,613,449.